175 related articles for article (PubMed ID: 26458449)
1. [Diagnosis and management of thrombotic microangiopathies].
Matsumoto M
Rinsho Ketsueki; 2015 Oct; 56(10):2092-9. PubMed ID: 26458449
[TBL] [Abstract][Full Text] [Related]
2. Thrombocytopenia in hospitalized patients: approach to the patient with thrombotic microangiopathy.
Scully M
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):651-659. PubMed ID: 29222317
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic microangiopathy and associated renal disorders.
Barbour T; Johnson S; Cohney S; Hughes P
Nephrol Dial Transplant; 2012 Jul; 27(7):2673-85. PubMed ID: 22802583
[TBL] [Abstract][Full Text] [Related]
4. Atypical Hemolytic Uremic Syndrome: Differential Diagnosis from TTP/HUS and Management.
Yenerel MN
Turk J Haematol; 2014 Sep; 31(3):216-25. PubMed ID: 25319590
[TBL] [Abstract][Full Text] [Related]
5. MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab.
Elhadad S; Chapin J; Copertino D; Van Besien K; Ahamed J; Laurence J
Clin Exp Immunol; 2021 Jan; 203(1):96-104. PubMed ID: 32681658
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy as a susceptible state for thrombotic microangiopathies.
Frimat M; Gnemmi V; Stichelbout M; Provôt F; Fakhouri F
Front Med (Lausanne); 2024; 11():1343060. PubMed ID: 38476448
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP/thrombotic microangiopathy registry.
Blombery P; Kivivali L; Pepperell D; McQuilten Z; Engelbrecht S; Polizzotto MN; Phillips LE; Wood E; Cohney S;
Intern Med J; 2016 Jan; 46(1):71-9. PubMed ID: 26477687
[TBL] [Abstract][Full Text] [Related]
8. [Genetics of aHUS and transplant recurrence].
Bresin E
G Ital Nefrol; 2015; 32 Suppl 64():. PubMed ID: 26479051
[TBL] [Abstract][Full Text] [Related]
9. [Atypic hemolytic uremic syndrome taken for Goodpasture's syndrome: A case report].
Bourgault M; Sarret D; Isnard P; Rabant M; Labaye J
Nephrol Ther; 2015 Dec; 11(7):564-8. PubMed ID: 26475667
[TBL] [Abstract][Full Text] [Related]
10. A De Novo Deletion in the Regulators of Complement Activation Cluster Producing a Hybrid Complement Factor H/Complement Factor H-Related 3 Gene in Atypical Hemolytic Uremic Syndrome.
Challis RC; Araujo GS; Wong EK; Anderson HE; Awan A; Dorman AM; Waldron M; Wilson V; Brocklebank V; Strain L; Morgan BP; Harris CL; Marchbank KJ; Goodship TH; Kavanagh D
J Am Soc Nephrol; 2016 Jun; 27(6):1617-24. PubMed ID: 26490391
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of haemolytic uremic syndrome in children. Data from the North Italian HUS network.
Ardissino G; Salardi S; Colombo E; Testa S; Borsa-Ghiringhelli N; Paglialonga F; Paracchini V; Tel F; Possenti I; Belingheri M; Civitillo CF; Sardini S; Ceruti R; Baldioli C; Tommasi P; Parola L; Russo F; Tedeschi S
Eur J Pediatr; 2016 Apr; 175(4):465-73. PubMed ID: 26498648
[TBL] [Abstract][Full Text] [Related]
12. Eculizumab use in kidney transplantation.
Johnson CK; Leca N
Curr Opin Organ Transplant; 2015 Dec; 20(6):643-51. PubMed ID: 26536427
[TBL] [Abstract][Full Text] [Related]
13. The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies.
Phillips EH; Westwood JP; Brocklebank V; Wong EK; Tellez JO; Marchbank KJ; McGuckin S; Gale DP; Connolly J; Goodship TH; Kavanagh D; Scully MA
J Thromb Haemost; 2016 Jan; 14(1):175-85. PubMed ID: 26559391
[TBL] [Abstract][Full Text] [Related]
14. Acute Systolic Heart Failure Associated with Complement-Mediated Hemolytic Uremic Syndrome.
Vaughn JL; Moore JM; Cataland SR
Case Rep Hematol; 2015; 2015():327980. PubMed ID: 26557394
[TBL] [Abstract][Full Text] [Related]
15. Eculizumab for the treatment of an atypical hemolytic uremic syndrome with mutations in complement factor I and C3.
Ferreira E; Oliveira N; Marques M; Francisco L; Santos A; Carreira A; Campos M
Nefrologia; 2016; 36(1):72-5. PubMed ID: 26541438
[No Abstract] [Full Text] [Related]
16. Case report of atypical hemolytic uremic syndrome with retinal arterial and venous occlusion treated with eculizumab.
Greenwood GT
Int Med Case Rep J; 2015; 8():235-9. PubMed ID: 26508891
[TBL] [Abstract][Full Text] [Related]
17. Long Standing Eculizumab Treatment without Anticoagulant Therapy in High-Risk Thrombogenic Paroxysmal Nocturnal Hemoglobinuria.
Al-Jafar HA; AlDallal SM; Askar HA; Aljeraiwi AM; Al-Alansari A
Hematol Rep; 2015 Sep; 7(3):5927. PubMed ID: 26487933
[TBL] [Abstract][Full Text] [Related]
18. A case of relapsing and refractory catastrophic anti-phospholipid syndrome successfully managed with eculizumab, a complement 5 inhibitor.
Wig S; Chan M; Thachil J; Bruce I; Barnes T
Rheumatology (Oxford); 2016 Feb; 55(2):382-4. PubMed ID: 26472567
[No Abstract] [Full Text] [Related]
19. Pregnancy-related thrombotic microangiopathies: Clues from complement biology.
Fakhouri F
Transfus Apher Sci; 2016 Apr; 54(2):199-202. PubMed ID: 27158062
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
